MiNK Therapeutics, Inc. Quarterly Preferred Stock, Shares Authorized for Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
MiNK Therapeutics, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate for Q4 2023.
  • MiNK Therapeutics, Inc. Preferred Stock, Shares Authorized for the quarter ending December 31, 2023 was 5M shares.
Preferred Stock, Shares Authorized, Quarterly (shares)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 5M Dec 31, 2023 10-K 2024-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.